Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Patel CB"" wg kryterium: Autor


Wyświetlanie 1-8 z 8
Tytuł :
Incorporating Shared Decision Making and Palliative Care Into Cardiogenic Shock Pathways.
Autorzy :
Warraich HJ
Patel CB
Kochar A
Rogers JG
Patel MR
Pokaż więcej
Źródło :
Journal of the American College of Cardiology [J Am Coll Cardiol] 2019 Jul 30; Vol. 74 (4), pp. 591-592.
Typ publikacji :
Letter; Research Support, Non-U.S. Gov't; Comment
MeSH Terms :
Palliative Care*
Shock, Cardiogenic*
Decision Making ; Decision Making, Shared ; Humans
Raport
Tytuł :
Cardiac Allograft Vasculopathy: A Formidable Foe.
Autorzy :
Patel CB; Cardiac Transplant Program, Division of Cardiology, Duke University Medical Center, Durham, North Carolina. Electronic address: chetan.patel@duke.edu.
Holley CL; Cardiac Transplant Program, Division of Cardiology, Duke University Medical Center, Durham, North Carolina.
Pokaż więcej
Źródło :
Journal of the American College of Cardiology [J Am Coll Cardiol] 2019 Jul 09; Vol. 74 (1), pp. 52-53.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Heart Transplantation*
Allografts ; Rituximab ; Transplantation, Homologous
Opinia redakcyjna
Tytuł :
Decline of Increased Risk Donor Offers on Waitlist Survival in Heart Transplantation.
Autorzy :
Mulvihill MS
Cox ML
Bishawi M
Osho AA
Yerokun BA
Wolfe CR
DeVore AD
Patel CB
Hartwig MG
Milano CA
Schroder JN
Pokaż więcej
Źródło :
Journal of the American College of Cardiology [J Am Coll Cardiol] 2018 Nov 06; Vol. 72 (19), pp. 2408-2409.
Typ publikacji :
Letter; Research Support, N.I.H., Extramural
MeSH Terms :
Tissue Donors*
Heart Transplantation/*mortality
Heart Transplantation/*trends
Waiting Lists/*mortality
Female ; Humans ; Male ; Registries ; Retrospective Studies ; Risk Factors ; Survival Rate/trends
Raport
Tytuł :
Palliative Care in Heart Failure: The PAL-HF Randomized, Controlled Clinical Trial.
Autorzy :
Rogers JG; Department of Medicine, Duke University School of Medicine, Durham, North Carolina; Duke Clinical Research Institute, Durham, North Carolina. Electronic address: .
Patel CB; Department of Medicine, Duke University School of Medicine, Durham, North Carolina; Duke Clinical Research Institute, Durham, North Carolina.
Mentz RJ; Department of Medicine, Duke University School of Medicine, Durham, North Carolina; Duke Clinical Research Institute, Durham, North Carolina.
Granger BB; Duke School of Nursing, Duke University, Durham, North Carolina.
Steinhauser KE; Department of Medicine, Duke University School of Medicine, Durham, North Carolina; Center for Health Services Research and Development in Primary Care, Durham VA Medical Center, Durham, North Carolina.
Fiuzat M; Department of Medicine, Duke University School of Medicine, Durham, North Carolina.
Adams PA; Department of Medicine, Duke University School of Medicine, Durham, North Carolina.
Speck A; Department of Medicine, Duke University School of Medicine, Durham, North Carolina.
Johnson KS; Department of Medicine, Duke University School of Medicine, Durham, North Carolina; Duke Clinical Research Institute, Durham, North Carolina.
Krishnamoorthy A; Piedmont HealthCare, Atlanta, Georgia.
Yang H; Duke Clinical Research Institute, Durham, North Carolina.
Anstrom KJ; Duke Clinical Research Institute, Durham, North Carolina; Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, North Carolina.
Dodson GC; Department of Medicine, Duke University School of Medicine, Durham, North Carolina.
Taylor DH Jr; Department of Medicine, Duke University School of Medicine, Durham, North Carolina; Sanford School of Public Policy, Duke University, Durham, North Carolina; Duke-Margolis Center for Health Policy, Duke University, Durham, North Carolina.
Kirchner JL; Duke Clinical Research Institute, Durham, North Carolina.
Mark DB; Department of Medicine, Duke University School of Medicine, Durham, North Carolina; Duke Clinical Research Institute, Durham, North Carolina.
O'Connor CM; Department of Medicine, Duke University School of Medicine, Durham, North Carolina; Inova Heart & Vascular Institute, Falls Church, Virginia.
Tulsky JA; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts; Division of Palliative Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Pokaż więcej
Źródło :
Journal of the American College of Cardiology [J Am Coll Cardiol] 2017 Jul 18; Vol. 70 (3), pp. 331-341.
Typ publikacji :
Journal Article; Randomized Controlled Trial
MeSH Terms :
Quality of Life*
Heart Failure/*therapy
Palliative Care/*methods
Aged ; Female ; Follow-Up Studies ; Heart Failure/diagnosis ; Humans ; Male ; Prospective Studies ; Severity of Illness Index ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Efficacy and Safety of Tolvaptan in Patients Hospitalized With Acute Heart Failure.
Autorzy :
Felker GM; Department of Medicine, Division of Cardiology, Duke University Medical Center, Durham, North Carolina; Duke Clinical Research Institute, Durham, North Carolina. Electronic address: .
Mentz RJ; Department of Medicine, Division of Cardiology, Duke University Medical Center, Durham, North Carolina; Duke Clinical Research Institute, Durham, North Carolina.
Cole RT; Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia.
Adams KF; Department of Medicine, Division of Cardiology, University of North Carolina, Chapel Hill, North Carolina.
Egnaczyk GF; The Ohio Heart and Vascular Center, The Christ Hospital, Cincinnati, Ohio.
Fiuzat M; Department of Medicine, Division of Cardiology, Duke University Medical Center, Durham, North Carolina; Duke Clinical Research Institute, Durham, North Carolina.
Patel CB; Department of Medicine, Division of Cardiology, Duke University Medical Center, Durham, North Carolina; Duke Clinical Research Institute, Durham, North Carolina.
Echols M; Department of Medicine, Division of Cardiology, Duke University Medical Center, Durham, North Carolina.
Khouri MG; Department of Medicine, Division of Cardiology, Duke University Medical Center, Durham, North Carolina.
Tauras JM; Albert Einstein College of Medicine, Bronx, New York.
Gupta D; Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia.
Monds P; Department of Medicine, Division of Cardiology, Duke University Medical Center, Durham, North Carolina; Duke Clinical Research Institute, Durham, North Carolina.
Roberts R; Department of Medicine, Division of Cardiology, Duke University Medical Center, Durham, North Carolina; Duke Clinical Research Institute, Durham, North Carolina.
O'Connor CM; Department of Medicine, Division of Cardiology, Duke University Medical Center, Durham, North Carolina.
Pokaż więcej
Źródło :
Journal of the American College of Cardiology [J Am Coll Cardiol] 2017 Mar 21; Vol. 69 (11), pp. 1399-1406. Date of Electronic Publication: 2016 Sep 18.
Typ publikacji :
Journal Article; Randomized Controlled Trial
MeSH Terms :
Antidiuretic Hormone Receptor Antagonists/*therapeutic use
Benzazepines/*therapeutic use
Heart Failure/*drug therapy
Aged ; Double-Blind Method ; Dyspnea/drug therapy ; Female ; Humans ; Kidney Function Tests ; Male ; Middle Aged ; Prospective Studies ; Tolvaptan
Czasopismo naukowe
Tytuł :
Prognostic Implications of Long-Chain Acylcarnitines in Heart Failure and Reversibility With Mechanical Circulatory Support.
Autorzy :
Ahmad T; Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, Connecticut; Department of Internal Medicine, Division of Cardiology, Duke University Medical Center, Durham, North Carolina. Electronic address: .
Kelly JP; Department of Internal Medicine, Division of Cardiology, Duke University Medical Center, Durham, North Carolina; Duke Clinical Research Institute, Duke University, Durham, North Carolina.
McGarrah RW; Department of Internal Medicine, Division of Cardiology, Duke University Medical Center, Durham, North Carolina; Duke Molecular Physiology Institute, Duke University, Durham, North Carolina.
Hellkamp AS; Duke Clinical Research Institute, Duke University, Durham, North Carolina.
Fiuzat M; Duke Clinical Research Institute, Duke University, Durham, North Carolina.
Testani JM; Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, Connecticut.
Wang TS; Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Verma A; Department of Internal Medicine, Division of Cardiology, Duke University Medical Center, Durham, North Carolina.
Samsky MD; Department of Internal Medicine, Division of Cardiology, Duke University Medical Center, Durham, North Carolina.
Donahue MP; Department of Internal Medicine, Division of Cardiology, Duke University Medical Center, Durham, North Carolina.
Ilkayeva OR; Duke Molecular Physiology Institute, Duke University, Durham, North Carolina.
Bowles DE; Division of Cardiac Surgery, Duke University Medical Center, Durham, North Carolina.
Patel CB; Department of Internal Medicine, Division of Cardiology, Duke University Medical Center, Durham, North Carolina; Duke Clinical Research Institute, Duke University, Durham, North Carolina.
Milano CA; Division of Cardiac Surgery, Duke University Medical Center, Durham, North Carolina.
Rogers JG; Department of Internal Medicine, Division of Cardiology, Duke University Medical Center, Durham, North Carolina; Duke Clinical Research Institute, Duke University, Durham, North Carolina.
Felker GM; Department of Internal Medicine, Division of Cardiology, Duke University Medical Center, Durham, North Carolina; Duke Clinical Research Institute, Duke University, Durham, North Carolina.
O'Connor CM; Duke Clinical Research Institute, Duke University, Durham, North Carolina; Inova Heart and Vascular Institute, Falls Church, Virginia.
Shah SH; Department of Internal Medicine, Division of Cardiology, Duke University Medical Center, Durham, North Carolina; Duke Molecular Physiology Institute, Duke University, Durham, North Carolina.
Kraus WE; Department of Internal Medicine, Division of Cardiology, Duke University Medical Center, Durham, North Carolina; Duke Molecular Physiology Institute, Duke University, Durham, North Carolina.
Pokaż więcej
Źródło :
Journal of the American College of Cardiology [J Am Coll Cardiol] 2016 Jan 26; Vol. 67 (3), pp. 291-9.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Heart Failure, Systolic*/diagnosis
Heart Failure, Systolic*/metabolism
Heart Failure, Systolic*/mortality
Heart Failure, Systolic*/physiopathology
Heart Failure, Systolic*/therapy
Carnitine/*analogs & derivatives
Exercise Therapy/*methods
Heart-Assist Devices/*statistics & numerical data
Aged ; Carnitine/metabolism ; Disease Progression ; Energy Metabolism/physiology ; Female ; Hospital Mortality ; Humans ; Male ; Mass Spectrometry/methods ; Middle Aged ; North Carolina ; Outcome Assessment, Health Care ; Prognosis ; Reproducibility of Results ; Severity of Illness Index ; Statistics as Topic
Czasopismo naukowe
Tytuł :
Trends in the use and outcomes of ventricular assist devices among medicare beneficiaries, 2006 through 2011.
Autorzy :
Khazanie P; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina; Department of Medicine, Duke University School of Medicine, Durham, North Carolina.
Hammill BG; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina.
Patel CB; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina; Department of Medicine, Duke University School of Medicine, Durham, North Carolina.
Eapen ZJ; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina; Department of Medicine, Duke University School of Medicine, Durham, North Carolina.
Peterson ED; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina; Department of Medicine, Duke University School of Medicine, Durham, North Carolina.
Rogers JG; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina; Department of Medicine, Duke University School of Medicine, Durham, North Carolina.
Milano CA; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina; Department of Medicine, Duke University School of Medicine, Durham, North Carolina.
Curtis LH; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina; Department of Medicine, Duke University School of Medicine, Durham, North Carolina.
Hernandez AF; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina; Department of Medicine, Duke University School of Medicine, Durham, North Carolina. Electronic address: .
Pokaż więcej
Źródło :
Journal of the American College of Cardiology [J Am Coll Cardiol] 2014 Apr 15; Vol. 63 (14), pp. 1395-404. Date of Electronic Publication: 2014 Jan 30.
Typ publikacji :
Comparative Study; Evaluation Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Health Care Costs*
Heart Failure/*surgery
Heart-Assist Devices/*economics
Heart-Assist Devices/*statistics & numerical data
Hospital Mortality/*trends
Medicare/*economics
Aged ; Cause of Death ; Confidence Intervals ; Databases, Factual ; Female ; Heart Failure/diagnosis ; Heart Failure/mortality ; Humans ; Male ; Middle Aged ; Patient Readmission/economics ; Patient Readmission/statistics & numerical data ; Postoperative Complications/diagnosis ; Postoperative Complications/economics ; Postoperative Complications/epidemiology ; Proportional Hazards Models ; Retrospective Studies ; Risk Assessment ; Survival Analysis ; Treatment Outcome ; United States
Czasopismo naukowe
Tytuł :
Cardiohepatic interactions in heart failure: an overview and clinical implications.
Autorzy :
Samsky MD; Duke Clinical Research Institute and the Department of Medicine, Duke University Medical Center, Durham, North Carolina.
Patel CB; Duke Clinical Research Institute and the Department of Medicine, Duke University Medical Center, Durham, North Carolina. Electronic address: chetan.patel@duke.edu.
DeWald TA; Duke Clinical Research Institute and the Department of Medicine, Duke University Medical Center, Durham, North Carolina.
Smith AD; Duke Clinical Research Institute and the Department of Medicine, Duke University Medical Center, Durham, North Carolina.
Felker GM; Duke Clinical Research Institute and the Department of Medicine, Duke University Medical Center, Durham, North Carolina.
Rogers JG; Duke Clinical Research Institute and the Department of Medicine, Duke University Medical Center, Durham, North Carolina.
Hernandez AF; Duke Clinical Research Institute and the Department of Medicine, Duke University Medical Center, Durham, North Carolina.
Pokaż więcej
Źródło :
Journal of the American College of Cardiology [J Am Coll Cardiol] 2013 Jun 18; Vol. 61 (24), pp. 2397-2405. Date of Electronic Publication: 2013 Apr 17.
Typ publikacji :
Journal Article; Research Support, U.S. Gov't, P.H.S.; Review
MeSH Terms :
Heart Failure/*complications
Heart Failure/*therapy
Liver Diseases/*complications
Albumins/metabolism ; Bilirubin/metabolism ; Cardiology/methods ; Heart Failure/metabolism ; Heart Failure/mortality ; Humans ; Liver/injuries ; Liver Function Tests ; Prognosis ; Treatment Outcome ; gamma-Glutamyltransferase/metabolism
Czasopismo naukowe
    Wyświetlanie 1-8 z 8

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies